Genpact subsidiaries price $350 million in senior notes at 4.95%

Genpact Limited announced a $350 million offering of 4.950% senior notes due 2030, with proceeds designated for general corporate purposes, including the potential refinancing of existing debt. This strategic move follows the professional services firm's strong third-quarter 2025 financial performance, where it surpassed analyst expectations with adjusted diluted EPS of $0.97 and revenue of $1.291 billion, highlighting its robust operational execution.

Analysis

Genpact Limited (G) has announced a $350 million offering of 4.950% senior notes due 2030, which will modestly increase its existing $1.43 billion debt position for the $7.77 billion market cap firm. The proceeds are earmarked for general corporate purposes, including the potential refinancing of its lower-coupon 1.750% senior notes due April 2026, indicating a strategic move to extend debt maturities. This issuance reflects a proactive approach to capital structure management, albeit at a higher cost of debt.

This debt offering follows Genpact's strong third-quarter 2025 financial performance, where the company significantly exceeded analyst expectations. Adjusted diluted earnings per share (EPS) reached $0.97, surpassing the $0.88 forecast, and revenue hit $1.291 billion, outperforming the anticipated $1.27 billion. These results highlight robust operational execution and a positive fundamental trajectory for the professional services provider.

Despite a slight stock decline post-earnings, the company's ability to outperform projections, coupled with its strategic debt issuance, suggests confidence in future cash flows and growth. Genpact, leveraging process intelligence and artificial intelligence, is positioning itself for continued investment in its core business, aligning with its focus on technology and innovation themes. The higher coupon on the new notes compared to the potential refinancing target indicates a rising cost of debt, a relevant market condition for investors to consider.

Key Decisions for Investors

• Investors should evaluate Genpact's debt strategy, noting the higher 4.950% coupon on new notes compared to the 1.750% notes potentially being refinanced, which indicates an increased cost of capital.
• Consider the strong Q3 2025 financial performance, with EPS and revenue beating estimates, as a positive indicator of operational strength and fundamental health.
• Monitor the actual deployment of the $350 million proceeds for general corporate purposes and any subsequent impact on the company's balance sheet and growth initiatives.